Eric Schlorff

CEO of SeaStar Medical

[Sai Iyer Ph.D @SaiIyerPhD]

Our CMO Dr. Kevin Chung gave a great talk on the SCD-PED at the Pediatric Nephrology Research Consortium meeting in Miami!

[Cyrus Askin, MD, FACP @Askins_Razor]

🚨⭐️Huge Release Alert⭐️🚨This week we return to cardiogenic shock by way of a wonderful discussion with @akkanti on #MCS! Give it a listen and let us know what you think! Thanks for the support @SeaStarMedical ‼️

[SeaStarMedical @SeaStarMedical]

Great to see #QUELIMMUNE getting a shout out in this month’s issue of @ASNKidney Kidney News magazine!

#ICU

https://t.co/iKLxary2se

[Kevin K. Chung, MD @chungk1031]

Proud to⁩ join ⁦@KidneyHealthIn⁩ as a corporate member!

Looking forward to participating in a panel discussion focused on biotech challenges.

⁦@SaiIyerPhD⁩ will also present an overview of our #SCD pipeline during the Innovator Fast Pitch session.

#QUELIMMUNE

[Sai Iyer Ph.D @SaiIyerPhD]

@chungk1031 giving the talk at PNRC and describing the 1st commercial QUELIMMUNE case at @UMich ! #QUELIMMUNE $ICU

[Kevin K. Chung, MD @chungk1031]

Our SVP of med affairs and research ⁦@SaiIyerPhD⁩ representing ⁦@SeaStarMedical⁩ at the CKD summit!

#QUELIMMUNE

[SeaStarMedical @SeaStarMedical]

We’re honored to receive the 2025 Corporate Innovator Award from the @NKF for our #QUELIMMUNE therapy — the first and only therapeutic device for treating pediatric AKI due to sepsis. We'll accept this award at #NKF2025 in Boston, April 9–13, 2025.

#ICU $ICU
Learn more here:
https://t.co/MW9VnvuIAM

[Kevin K. Chung, MD @chungk1031]

We will get there…

How do I know?

Because I have complete trust in our world class @SeaStarMedical team and all of our fantastic site champions and trial investigators.

#QUELIMMUNE
#NEUTRALIZEAKI

[SeaStarMedical @SeaStarMedical]

We’re excited to be attending the 30th AKI-CRRT Meeting in San Diego, CA! Come visit us at Booth #7 to learn more about QUELIMMUNE and our #SCD technology! #AKICRRT25 #ICU

[Kevin K. Chung, MD @chungk1031]

Selective Cytopheretic Device getting major playing time at #AKICRRT2025!

Thank you @slgold777 for getting this topic in this year’s program.

Shout out to Dr. Humes!

@SeaStarMedical

[Kevin K. Chung, MD @chungk1031]

Thanks for calling out #NEUTRALIZEAKI!

Awesome talk as always.

@slgold777

[Kevin K. Chung, MD @chungk1031]

Welcoming @MayoClinic to #NEUTRALIZEAKI!

@SeaStarMedical

https://t.co/yUqCFmv5Mi

[Kevin K. Chung, MD @chungk1031]

Slow and steady wins the race.

Grateful we are able to give critically ill children a fighting chance when no other options exist.

⁦@SeaStarMedical⁩

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer | SeaStar Medical https://t.co/kcqCbybkiF

[Sai Iyer Ph.D @SaiIyerPhD]

It was a pleasure to catch up with the legendary Dr. Bert Pitt and attend his talk about systemic inflammation in HF and SCD data in cardiorenal syndrome at the CVCT Forum in DC!
#ICU $ICU

[SeaStarMedical @SeaStarMedical]

In this newly published paper, led by Dr. Jeffrey Dellavolpe and team, read about the role our SCD played in a groundbreaking sequential extracorporeal treatment strategy of a 28-year-old patient who developed streptococcal toxic shock syndrome with multi-organ failure.

https://t.co/HgDtNGL1Rb

#medicalpaper #medicaljournal #ICU

[SeaStarMedical @SeaStarMedical]

SeaStar Medical will be holding investment community meetings Jan. 8-11 at J.P. Morgan Healthcare week in San Francisco. Join CEO, Eric Schlorff @SchlorffEric and CMO Kevin Chung, MD. @chungk1031

For more information, contact Jody Cain at LHA Investor Relations: [email protected]

[Nature Reviews Nephrology @NatRevNeph]

Pathophysiology of #AKI in patients with burns from a Review by Matthieu Legrand, @audra_clark87, @javo_neyra & @MarliesOsterman https://t.co/lwQLwQTSFp

[SeaStarMedical @SeaStarMedical]

"SeaStar Medical Gets Third Breakthrough Nod for Selective Cytopheretic Device" - view the full article on
BioWorld HERE: https://t.co/xYzlRzPXy5 #mednews #bioworld
#medtech #ICU $ICU

[SeaStarMedical @SeaStarMedical]

This week, our Chief Medical Officer and retired Army physician, Dr. Kevin Chung, MD, spoke at the session "Cellular Therapeutics for Treatment of Shock and Trauma at the Military Health System Research Symposium" (MHSRS) about the life-saving potential of our SCD device #MHSRS

[Eric Schlorff @SchlorffEric]

@SeaStarMedical Such an important paper that highlights the impact on critically ill children…and their parents. Makes me smile every time I think about those fortunate parents that are able to spend the future with their child. $icu